Product Introduction
Bioactivity


英文名: Chiglitazar

描述: Chiglitazar is a dual agonist of PPARα/γ (EC50s: 1.2, 0.08, and 1.7 μM for PPARα, PPARγ, and PPARδ).

体外活性: Chiglitazar shows weaker PPARγ activating activity than rosiglitazone, but stronger than pioglitazone. In terms of PPARα activation, Chiglitazar shows a more potent activity than rosiglitazone, pioglitazone, or WY14643 which is a selective PPARα agonist [1].

体内活性: Plasma glucose levels in the MSG rats treated with Chiglitazar or rosiglitazone are significantly reduced compared with the control group treated with the vehicle, after insulin injection. Fasting PI levels are lower in animals treated with Chiglitazar and rosiglitazone than control. Chiglitazar ameliorates the HOMA indices. For IPGTT, at the 30?min after glucose loading, the glucose values in the 5 and 10?mg/kg Chiglitazar and rosiglitazone-treatment groups are significantly lower than those in the vehicle treatment group [1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: Chiglitazar

相关产品: (S)-Coriolic acid | Elafibranor | L-165041 | 1-Hydroxy-2-oxopomolic acid | Norathyriol | Lanifibranor | NTP42 | G3335 Acetate | Dihydrocurcumin | Bocidelpar